Pharmacodynamic Material Basis and Pharmacological Mechanism of Huangqi Guizhi Wuwu Granules in Diabetic Peripheral Neuropathy
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Yang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jilin Medical University, Jilin, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Diabetic Neuropathies. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation Project from the Department of Science and Technology of Jilin Province, Innovation and Entrepreneurship Talent Project from the Department of Human Resources and Social Security of Jilin Province.
Abstract (Originalsprache)
Huangqi Guizhi Wuwu Decoction (HGWD) is a traditional Chinese medicine (TCM) formula used to treat diabetic peripheral neuropathy (DPN) in China. Considering that the decoction was not easy to carry and use, we have prepared HGWD into Huangqi Guizhi Wuwu Granules (HGWG). However, the active components of HGWG that can be absorbed into plasma and its mechanism of action for DPN treatment remain unclear. In the present study, UHPLC‐Q‐TOF‐MS and network pharmacology methods were applied to explore the potential pharmacodynamic material basis and pharmacological mechanism of HGWG for the treatment of DPN. A total of 31 absorbed components were detected in rat plasma, including 20 prototype compounds and 11 metabolites. Flavonoid‐related metabolites and gingerol‐related metabolites were major metabolites. The network pharmacological analysis showed that 31 absorbed constituents regulated 122 pathways through 177 targets; among them, baicalein, paeoniflorin C, and 6‐gingerol were the main pharmacodynamic components of HGWG for DPN. It can be concluded that monoterpenoid glycosides, flavonoids, organic acids, gingerols, flavonoid‐related metabolites, and gingerol‐related metabolites were the main pharmacodynamic material basis of HGWG for DPN, and the mechanism of HGWG for DPN may be related to reducing oxidative stress and inhibiting neuroinflammation by stimulating the phosphorylation of p38 MAPK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jilin Medical University, Jilin, China.
- School of Pharmacy, Yanbian University, Jilin, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation Project from the Department of Science and Technology of Jilin Province
- Innovation and Entrepreneurship Talent Project from the Department of Human Resources and Social Security of Jilin Province
Zitieren
APA
Liu, Y., Li, L., Yang, Y., Wang, X., Ge, S., Jin, L., Feng, B., Guan, J., & Zhu, H. (2025). Pharmacodynamic Material Basis and Pharmacological Mechanism of Huangqi Guizhi Wuwu Granules in Diabetic Peripheral Neuropathy. Biomedical Chromatography. https://doi.org/10.1002/bmc.70127
Vancouver
Liu Y, Li L, Yang Y, Wang X, Ge S, Jin L, et al. Pharmacodynamic Material Basis and Pharmacological Mechanism of Huangqi Guizhi Wuwu Granules in Diabetic Peripheral Neuropathy. Biomedical Chromatography. 2025. doi:10.1002/bmc.70127
BibTeX
@article{Liu2025,
author = {Liu, Yang and Li, Lele and Yang, Yan and Wang, Xing and Ge, Shengyu and Jin, Lili and Feng, Bo and Guan, Jiao and Zhu, Heyun},
title = {Pharmacodynamic Material Basis and Pharmacological Mechanism of Huangqi Guizhi Wuwu Granules in Diabetic Peripheral Neuropathy},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70127}
}
EUVIMED